Revelation Biosciences, Inc. (REVBW) Ownership

$0.01

south_east
-$0 (-0.8%)
Day's range
$0.01
Day's range
$0.01

Revelation Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LINDEN ADVISORS LP 11/14/2025 338.11 K $3.91 K   0.00% 12.78%
CLEAR STREET GROUP INC. 11/14/2025 247.43 K $3.09 K   100.00% 9.36%
TORONTO DOMINION BANK 11/14/2025 99.45 K $1.29 K   -0.15% 3.76%
WOLVERINE ASSET MANAGEMENT LLC 10/28/2025 54.75 K $684   0.00% 2.07%
JANE STREET GROUP, LLC 11/14/2025 50.00 K $580   0.00% 1.89%
SOLTIS INVESTMENT ADVISORS LLC 11/12/2025 47.50 K $499   0.00% 1.80%
CITADEL ADVISORS LLC 11/14/2025 31.80 K $321   -11.79% 1.20%
UBS GROUP AG 11/13/2025 1.13 K $12   -12.85% 0.04%
POM INVESTMENT STRATEGIES, LLC 11/12/2025 1.01 K $11   0.00% 0.04%
QUAKER WEALTH MANAGEMENT, LLC 11/05/2025 387 $5   0.00% 0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 0 $0   -100.00% 0.00%

Revelation Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 17 institutional investors and hedge funds held shares of Revelation Biosciences, Inc.. The most heavily invested institutionals were:

LINDEN ADVISORS LP: 338,110

Clear Street Group Inc.: 247,434

TORONTO DOMINION BANK: 99,450

WOLVERINE ASSET MANAGEMENT LLC: 54,752

JANE STREET GROUP, LLC: 50,000

Soltis Investment Advisors LLC: 47,500

32.95% of Revelation Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.77 M shares in the last 24 months. This purchase volume represents approximately $17.70 K in transactions.